Vizgen
Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The company's MERSCOPE Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution. MERSCOPE provides transformative insight into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, infectious disease, developmental biology, cell and gene therapy, and is an essential tool for accelerating drug discovery and development.
Work at Vizgen in HR or recruiting? Claim this page
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Funding
- Jun 2022 · Series C · $85.2M · Blue Water Life Science Advisors, ARCH Venture Partners, Northpond Ventures
- Apr 2021 · Series B · $37M · Novalis LifeSciences LLC, Northpond Ventures, Tao Capital Partners
- Jan 2020 · Series A · $14M · ARCH Venture Partners, Northpond Ventures
Peer reviews
Worked with someone at Vizgen?
Anonymous peer reviews on OffTheRecord
Similar companies
Vizgen FAQ
How many employees does Vizgen have?
Vizgen has about 190 employees (as of Oct 2026).
Does Vizgen sponsor H1B visas?
Yes. Vizgen filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Vizgen's revenue per employee?
Vizgen makes about $16K in revenue per employee, based on $3M annual revenue and 190 employees.
How much funding has Vizgen raised?
Vizgen has raised $136.2M in total funding; its latest round was Series C in Jun 2022.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.